Highlights • Screening efforts to diagnose unknown HBV and HCV infections in the general population are a major component of elimination efforts. • A structured viral hepatitis screening program at the primary care level leads to large additional effects compared to routine care. • Compared to 30,106 HBsAg and 31,266 anti-HCV lab requests in 2018, 286,192 tests were requested during the screening period. • Prevalences of HBsAg, anti-HCV and HCV RNA were 0.54%, 0.79% and 0.13%, respectively, in the German population.
All Keywords
【저자키워드】 Elimination, WHO, Anti-HCV, HBsAg, HBV DNA, HCV RNA,
【저자키워드】 Elimination, WHO, Anti-HCV, HBsAg, HBV DNA, HCV RNA,